Subgroups, reanalyses, and other dangerous things

被引：6

作者：

Wears, RL

Cooper, RJ

Magid, DJ

机构：

[1] Univ Florida, Hlth Sci Ctr, Dept Emergency Med, Jacksonville, FL 32209 USA

[2] Univ London Imperial Coll Sci Technol & Med, Clin Safety Res Unit, London, England

[3] Univ Calif Los Angeles, Dept Emergency Med, Los Angeles, CA USA

[4] Kaiser Permanente Colorado Clin Res Unit, Denver, CO USA

[5] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA

[6] Univ Colorado, Hlth Sci Ctr, Dept Emergency Med, Denver, CO USA

来源：

ANNALS OF EMERGENCY MEDICINE | 2005年 / 46卷 / 03期

关键词：

D O I：

10.1016/j.annemergmed.2005.05.007

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：253 / 255

页数：3

共 18 条

[1]

[Anonymous], 1988, J AM COLL CARDIOL, V12, pA3

[2] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].

APPLEBY, P ;

BAIGENT, C ;

COLLINS, R ;

FLATHER, M ;

PARISH, S ;

PETO, R ;

BELL, P ;

HALLS, H ;

MEAD, G ;

DIAZ, R ;

PAOLASSO, E ;

PAVIOTTI, C ;

ROMERO, G ;

CAMPBELL, T ;

OROURKE, MF ;

THOMPSON, P ;

LESAFFRE, E ;

VANDEWERF, F ;

VERSTRAETE, M ;

ARMSTRONG, PW ;

CAIRNS, JA ;

MORAN, C ;

TURPIE, AG ;

YUSUF, S ;

GRANDE, P ;

HEIKKILA, J ;

KALA, R ;

BASSAND, JP ;

BOISSEL, JP ;

BROCHIER, M ;

LEIZOROVICZ, A ;

BRUGGEMANN, T ;

KARSCH, KR ;

KASPER, W ;

LAMMERTS, D ;

NEUHAUS, KL ;

MEYER, J ;

SCHRODER, R ;

VONESSEN, R ;

SARAN, RK ;

ARDISSINO, D ;

BONADUCE, D ;

BRUNELLI, C ;

CERNIGLIARO, C ;

FORESTI, A ;

FRANZOSI, MG ;

GUIDUCCI, D ;

MAGGIONI, A ;

MAGNANI, B ;

MATTIOLI, G .

LANCET, 1994, 343 (8893) :311-322

[3] WHY SOME HEALTH POLICIES DONT MAKE SENSE AT THE BEDSIDE [J].

ASCH, DA ;

HERSHEY, JC .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (11) :846-850

[4] Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].

Assmann, SF ;

Pocock, SJ ;

Enos, LE ;

Kasten, LE .

LANCET, 2000, 355 (9209) :1064-1069

[5] Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Experience [J].

Broderick, JP ;

Brott, T ;

DeGraba, T ;

Fagan, SC ;

Frankel, MR ;

Grotta, JC ;

Haley, EC ;

Hamilton, S ;

Kwiatkowski, T ;

Levine, SR ;

Lewandowski, CA ;

Lin, Y ;

Libman, R ;

Lu, M ;

Lyden, P ;

Marler, JR ;

Morgenstern, L ;

Patel, S ;

Sanders, C ;

Tilley, BC .

ANNALS OF EMERGENCY MEDICINE, 2005, 46 (03) :243-252

[6]

Brookes S T, 2001, Health Technol Assess, V5, P1

[7] Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test [J].

Brookes, ST ;

Whitely, E ;

Egger, M ;

Smith, GD ;

Mulheran, PA ;

Peters, TJ .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (03) :229-236

[8] Problems in the "evidence" of "evidence-based medicine" [J].

Feinstein, AR ;

Horwitz, RI .

AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06) :529-535

[9]

LANG TA, 1997, REPORT STAT MED ANNO, P81

[10] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].

MARLER, JR ;

BROTT, T ;

BRODERICK, J ;

KOTHARI, R ;

ODONOGHUE, M ;

BARSAN, W ;

TOMSICK, T ;

SPILKER, J ;

MILLER, R ;

SAUERBECK, L ;

JARRELL, J ;

KELLY, J ;

PERKINS, T ;

MCDONALD, T ;

RORICK, M ;

HICKEY, C ;

ARMITAGE, J ;

PERRY, C ;

THALINGER, K ;

RHUDE, R ;

SCHILL, J ;

BECKER, PS ;

HEATH, RS ;

ADAMS, D ;

REED, R ;

KLEI, M ;

HUGHES, S ;

ANTHONY, J ;

BAUDENDISTEL, D ;

ZADICOFF, C ;

RYMER, M ;

BETTINGER, I ;

LAUBINGER, P ;

SCHMERLER, M ;

MEIROSE, G ;

LYDEN, P ;

RAPP, K ;

BABCOCK, T ;

DAUM, P ;

PERSONA, D ;

BRODY, M ;

JACKSON, C ;

LEWIS, S ;

LISS, J ;

MAHDAVI, Z ;

ROTHROCK, J ;

TOM, T ;

ZWEIFLER, R ;

DUNFORD, J ;

ZIVIN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587

← 1 2 →